Addition of Ceftriaxone and Amikacin to a Ciprofloxacin plus Metronidazole Regimen for Preventing Infectious Complications of Transrectal Ultrasound-Guided Prostate Biopsy: A Randomized Controlled Trial

Table 1

Distribution of basic and prostate variables in both groups.

Variables		Groups
		Control	Intervention
Number		216	219	—
Age (year)				0.56
Indication for biopsy	Elevated PSA ± abnormal DRE	201 (93.1)	209 (95.4)	0.94
	Abnormal DRE + normal PSA	4 (1.9)	1 (0.5)
	History of prostate cancer	8 (3.7)	7 (3.1)
	History of ASAP or PIN	3 (1.3)	2 (0.9)
PSA (ng/ml)				0.11
% fPSA/total PSA (N)		(71)	(60)	0.35
Transition zone volume (N)		(166)	(117)	0.59
Total prostatic volume (cc)				0.39